01-11-2021, 02:34 PM
Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to Approximately $102.0 Million
Saint-Herblain (France), November 1, 2021 – Valneva SE, a specialty vaccine company, announced today that the underwriters of its global offering of an aggregate of 4,500,000 new ordinary shares, consisting of a private placement of 4,466,880 ordinary shares in Europe (including in France) and other countries outside of the United States (the “European Private Placement”) and a concurrent public offering of 16,560 American Depositary Shares (“ADSs”), each representing two ordinary shares (the “U.S. Offering”, and, together with the European Private Placement, the “Global Offering”), have exercised in full their option to purchase up to 675,000 additional new ordinary shares in the form of 337,500 ADSs. The additional ADSs will be delivered concurrently with the closing of the Global Offering on or about November 2, 2021.
https://www.globenewswire.com/news-relea...llion.html
Saint-Herblain (France), November 1, 2021 – Valneva SE, a specialty vaccine company, announced today that the underwriters of its global offering of an aggregate of 4,500,000 new ordinary shares, consisting of a private placement of 4,466,880 ordinary shares in Europe (including in France) and other countries outside of the United States (the “European Private Placement”) and a concurrent public offering of 16,560 American Depositary Shares (“ADSs”), each representing two ordinary shares (the “U.S. Offering”, and, together with the European Private Placement, the “Global Offering”), have exercised in full their option to purchase up to 675,000 additional new ordinary shares in the form of 337,500 ADSs. The additional ADSs will be delivered concurrently with the closing of the Global Offering on or about November 2, 2021.
https://www.globenewswire.com/news-relea...llion.html